CNBS vs MSOS

Key Takeaways

• Both CNBS and MSOS are actively managed exchange-traded funds (ETFs) providing exposure to the cannabis sector, but they differ in geographic focus and portfolio construction.
• CNBS offers diversified exposure across the global cannabis ecosystem, including plant operations, support services, and ancillary businesses, while MSOS concentrates exclusively on U.S. multi-state operators (MSOs) and domestic cannabis companies.
• Expense ratios are similar, with CNBS at a net 0.76% and MSOS at approximately 0.78%, reflecting the higher costs associated with active management in this niche sector.
• CNBS typically maintains a broader holdings base that may include derivatives such as total return swaps and select fixed-income instruments, whereas MSOS relies more heavily on swaps for U.S.-focused exposure.
• Structural differences position CNBS for potentially wider thematic diversification and MSOS for concentrated bets on U.S. regulatory and market developments.
• Both funds carry elevated volatility typical of the cannabis industry, influenced by regulatory shifts, state-level legalization, and evolving federal policy.

Introduction

The cannabis sector continues to attract investor interest amid ongoing regulatory evolution and expanding state-level markets in the United States. CNBS and MSOS represent two distinct active strategies within this thematic space. Rather than direct competitors, they offer alternative approaches to cannabis exposure: one with a broader ecosystem view and the other with a strict domestic focus. Investors comparing these exchange-traded funds (ETFs) often seek to understand how differences in mandate, holdings, and costs influence relative positioning within the same high-growth but volatile industry.

Amplify Seymour Cannabis ETF (CNBS) Overview

CNBS is an actively managed ETF launched in 2019 that seeks capital appreciation by investing in companies deriving significant revenue from the cannabis and hemp ecosystem. The fund classifies holdings into plant operations (cultivation, retail, pharmaceuticals), support services (agricultural technology, real estate), and ancillary businesses (devices, technology, media). It typically holds 35–45 securities, often incorporating total return swaps alongside equities and occasional U.S. Treasury positions for liquidity management. The net expense ratio stands at 0.76%. Active management allows portfolio adjustments in response to sector dynamics, distinguishing it from passive index trackers.

AdvisorShares Pure US Cannabis ETF (MSOS) Overview

MSOS is an actively managed ETF launched in 2020 that targets long-term capital appreciation through exposure to U.S. companies engaged in the marijuana and hemp business. The strategy focuses exclusively on domestic multi-state operators (MSOs) and related entities, investing at least 80% of assets in qualifying securities or derivatives with similar economic characteristics. Portfolio construction frequently employs total return swaps to access U.S.-listed or over-the-counter cannabis equities. The expense ratio is approximately 0.78%. This pure-play U.S. mandate creates a more concentrated risk profile tied to American regulatory and market conditions.

Industry and Thematic Backdrop

The cannabis industry operates in a fragmented regulatory environment where state-level legalization drives growth while federal policy, including potential rescheduling, remains a key catalyst. Macroeconomic factors such as interest rate expectations and consumer spending patterns influence capital allocation to high-risk thematic sectors. Both ETFs face risks from policy uncertainty, competition among operators, and commodity-like pricing pressures on cannabis products. Recent market cycles have highlighted sensitivity to broader equity sentiment and sector-specific news flow around banking access and interstate commerce.

Performance and Positioning Comparison

In recent market cycles, performance differences between the two exchange-traded funds (ETFs) have reflected their distinct mandates. CNBS broader ecosystem exposure has at times provided modest diversification benefits during periods of U.S.-specific volatility, while MSOS has shown stronger correlation to domestic multi-state operator (MSO) earnings and state regulatory announcements. Both funds exhibit elevated volatility relative to broad market benchmarks, with positioning influenced by sector rotation into or out of cannabis themes amid shifting interest rate outlooks and capital flows. Relative strength has varied with the pace of U.S. market expansion versus international developments.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover additional opportunities aligned with your strategy.

Tickeron AI Verdict

Based on observable structural factors, Tickeron’s AI would likely assign a modest edge to CNBS at present. Its slightly lower net expense ratio, broader ecosystem diversification across plant, support, and ancillary segments, and flexible use of holdings including fixed-income instruments support a more balanced risk profile within the cannabis theme. MSOS offers compelling concentrated U.S. exposure, yet its narrower mandate introduces higher sensitivity to domestic regulatory outcomes. The probabilistic assessment favors CNBS for investors prioritizing cost efficiency and thematic breadth in current conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations